The Abortion Pill's Exile in Obscurity

Listen to the Story - A podcast by Bloomberg

Categories:

Business

Twenty-one years after its approval by the FDA, mifepristone could—but probably won’t— revolutionize a post-Roe world.  By Cynthia KoonsSee omnystudio.com/listener for privacy information.